Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reversible chorea in primary antiphospholipid syndrome

J Sundén-Cullberg1, J Tedroff, S M Aquilonius

  • 1Department of Neurology, University Hospital, Uppsala, Sweden.

Movement Disorders : Official Journal of the Movement Disorder Society
|February 6, 1998
PubMed
Summary

Acute chorea, a movement disorder, was studied in a patient with antiphospholipid syndrome using positron emission tomography (PET). PET revealed increased metabolism in the basal ganglia during chorea, supporting the hypermetabolism theory for acute choreas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

(3<i>S</i>)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent.

The Journal of pharmacology and experimental therapeutics·2020
Same author

The dopaminergic stabilizer pridopidine is to a major extent N-depropylated by CYP2D6 in humans.

European journal of clinical pharmacology·2012
Same author

Adenosine infusion attenuates soluble RAGE in endotoxin-induced inflammation in human volunteers.

Acta physiologica (Oxford, England)·2009
Same author

Objective assessment of cervical dystonia: a pilot study.

Acta neurologica Scandinavica·2005
Same author

Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1.

Scandinavian journal of immunology·2004
Same author

PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's disease.

Neuropharmacology·2002

Failed At:

2026-06-19T13:35:14.780115+00:00

Related Experiment Videos